HIV 1 News and Research

RSS

PAHO vaccines books wins major award

The Pan American Health Organization’s publication, Vaccines: Preventing Disease and Protecting Health, has won an award from the Association of American Publishers in the medical science category.

9 Feb 2005

Many alcohol dependent HIV patients need assistance adhering to medications

Supervised medication delivery or simplified dosing regimens may be needed to ensure that HIV-infected patients with a history of alcohol problems stick to their medication regimens, according to a new study by researchers at Boston University Medical Center.

8 Feb 2005

India trials investigational vaccine candidate designed to prevent HIV/AIDS

Announcing the trial, Union Minister of Health and Family Welfare Dr. Anbumani Ramadoss, said: "Developing a vaccine to prevent AIDS is one of the most difficult scientific challenges of our time. It is also one of the most urgent health needs. Perseverance is the way forward, and India has a long- term commitment."

7 Feb 2005

Finding points towards the possibility of retrovirus involvement in ALS (amyotrophic lateral sclerosis)

A significant proportion of patients suffering from ALS (amyotrophic lateral sclerosis), also known as Lou Gehrig's disease or motor neuron disease, have a marker of retrovirus activity in their blood, reports the February 8 issue of the medical journal Neurology.

7 Feb 2005

HIV-infected parents peport limiting physical contact with their children

Over one-fourth of HIV-infected parents reported avoiding certain physical interactions, like hugging or kissing, with their children due to a fear of transmitting the disease or of contracting an infection from them, according to an article in the February issue of Archives of Pediatrics & Adolescent Medicine.

7 Feb 2005

Sexual behaviour study of Nepalese trekking guides

Researchers in Aberdeen have begun a study into the sexual behaviour of trekking guides in one of the world’s fastest growing adventure destinations.

7 Feb 2005

Malaria experts to unveil top-flight research during international conference

Some of the world’s leading authorities on tropical diseases and parasitic infections will gather for an international conference at The University of Nottingham to discuss the latest breakthroughs in research and treatments.

3 Feb 2005

No association between a herpesvirus infection and pulmonary hypertension

Contrary to the results of a recent U.S. study, investigators in Japan found no association between a herpesvirus infection and a potentially life-threatening form of high blood pressure, as reported in the March 1 issue of The Journal of Infectious Diseases, now available online.

30 Jan 2005

Needlestick injuries in healthcare workers still occurring

The latest Health Protection Agency report on the occupational exposure of healthcare workers (HCWs) to bloodborne viruses (BBVs) shows that nine healthcare workers were infected with hepatitis C through needlestick injuries over the last six years, with seven reported between July 2003 and June 2004.

27 Jan 2005

US rates of early death and disability from sexual behaviour triple those of other wealthy nations

The rates of premature death and disability attributable to sexual behaviour in the United States are triple those of other wealthy nations, suggests research in Sexually Transmitted Infections.

26 Jan 2005

Tentative approval of co-packaged lamivudine/zidovudine fixed dose combination tablets and nevirapine tablets

The Food and Drug Administration (FDA) has announced the tentative approval of a co-packaged antiretroviral drug regimen manufactured by Aspen Pharmacare of South Africa for the treatment of HIV-1 infection in adults.

26 Jan 2005

Migration and Aids: social control, a brake on the spread of HIV in Senegal?

Ever since Aids appeared, migration has been thought to be a driving force behind the epidemic. The disease is often represented either as an “imported pathology”, migrants being the disease (or at least risk), carriers or as a “pathology of adaptation”.

25 Jan 2005

New highly active agents against leishmaniasis

Parasitic diseases, especially leishmaniases and trypanosomiases, kill hundreds of thousands of people every year in the world, mainly in the countries of the South. The most severe form of leishmaniosis (kala-azar, the visceral form), induced by Leishmania donovani and L. infantum, affects about 500 000 people per year and proves fatal if no treatment is given.

25 Jan 2005

Viacom and Kaiser launch year three of KNOW HIV/AIDS campaign

Viacom Inc. and the Henry J. Kaiser Family Foundation today announced the year-three launch of the Emmy and Peabody Award-winning public education initiative KNOW HIV/AIDS, which includes targeted public service announcements (PSAs), HIV-themed programming, and free print and online information resources.

24 Jan 2005

Living in a disadvantaged neighborhood may increase HIV risk

Living in a disadvantaged urban neighborhood can increase a male residents’ risk of contracting HIV, according to researchers at the Johns Hopkins Bloomberg School of Public Health. Their study related disadvantaged neighborhoods to stress and stress to increased injection drug use in male study participants.

24 Jan 2005

Serono completes enrollment in phase III trial of Serostim

Serono has announced that it has completed enrollment in its second multi-center, phase III trial of Serostim (somatropin [rDNA origin] for injection) in the treatment of HIV-Associated Adipose Redistribution Syndrome (HARS).

24 Jan 2005

New federal guidelines for the use of antiretroviral drugs to prevent HIV infection

The Centers for Disease Control and Prevention (CDC) today announced new federal guidelines for the use of antiretroviral drugs to prevent HIV infection after exposure to HIV through sexual intercourse, sexual assault, injection drug use, or accidents.

20 Jan 2005

Uncircumcised men have more than twice the risk of acquiring HIV

The first study to examine the probability of HIV infection per act of heterosexual sex among a population with multiple sexual partners has found that uncircumcised men have more than twice the risk of acquiring HIV than do circumcised men.

20 Jan 2005

NIH begins Phase 1 clinical trial of HIV vaccine candidate

GenVec announced today that the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), has begun the second Phase 1 clinical trial in healthy adult volunteers of an HIV vaccine candidate jointly developed by the Dale and Betty Bumpers Vaccine Research Center (VRC), a part of NIAID, and GenVec.

19 Jan 2005

Home HIV-AIDS test could be a reality within two years

A portable device similar to a home pregnancy test that can quickly detect the presence of infectious diseases, including HIV-AIDS and measles as well as biological agents such as Ricin and anthrax, is the goal of a new joint research project

17 Jan 2005